Kidney damage caused by medications, known as drug-induced kidney injury or nephrotoxicity, is a frequent issue in medical ...

New SER-155 Phase 1b study biomarker data in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients demonstrate that SER-155 promoted epithelial barrier integrity and decreased ...

Drug-induced kidney injury, or nephrotoxicity, is a common complication in clinical medicine that happens when drugs damage ...

Syngenta and the pioneering artificial intelligence (AI) company TraitSeq are combining forces to use the full power of AI ...

The platform analyses gene expression and cell states specific to individual cells, offering insights for disease diagnosis.

Researchers have identified six new biomarkers that could detect kidney injury faster and with more sensitivity, advancing safer drug development and improving health outcomes for patients. The new ...

There’s gouda news for cheese lovers. A recent study found cheese eaters are less likely to have sleep apnea than their dairy ...

NYU researchers found that declining acetyl-L-carnitine and free carnitine levels correlate with Alzheimer’s severity, ...

BARDA tapped a team of Fred Hutch Cancer Center biostatisticians to determine the biomarkers that will serve as predictors of ...

Those key challenges impacting the care of respiratory diseases include delays in diagnosis due to the intermittent nature of ...

TMB and various biomarkers were positively associated with improved pCR and EFS in high-risk, early-stage TNBC, regardless of ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with Genialis, the RNA-biomarker company.